Hepion Pharmaceuticals (HEPA) Institutional Ownership $0.32 -0.15 (-31.39%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Hepion Pharmaceuticals (NASDAQ:HEPA)CurrentInstitutional OwnershipPercentage17.24%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$349.94KNumber ofInstitutional Sellers(last 12 months)0 Get HEPA Insider Trade Alerts Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HEPA Institutional Buying and Selling by Quarter Hepion Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Anson Funds Management LP231,849$155K0.0%N/A3.331% 8/15/2024Armistice Capital LLC516,000$526K0.0%+32.3%9.428% 2/13/2024Armistice Capital LLC418,000$1.35M0.0%+5.1%9.631% 11/15/2023Armistice Capital LLC397,607$1.98M0.0%N/A10.360% 5/1/2023Virtu Financial LLC53,501$42K0.0%+152.8%0.070% 11/7/2022Virtu Financial LLC67,802$34K0.0%+195.6%0.089% 10/13/2022PVG Asset Management Corp107,915$55K0.2%N/A0.142% 8/12/2022Ikarian Capital LLC410,189$235K0.0%-29.5%0.538% 2/4/2022Envestnet Asset Management Inc.72,027$82K0.0%+87.5%0.094% 2/2/2022PVG Asset Management Corp100,089$114K0.4%+92.5%0.131% Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/10/2021PVG Asset Management Corp51,989$80K0.2%-72.6%0.068% 11/9/2021BlackRock Inc.1,634,012$2.50M0.0%-1.0%2.144% 11/5/2021PNC Financial Services Group Inc.39,034$60K0.0%N/A0.051% 10/13/2021Asset Management Corp IL ADV133,500$204K0.1%+45.9%0.175% 9/17/2021Virtu Financial LLC113,869$225K0.0%-36.4%0.149% 8/18/2021Ikarian Capital LLC1,365,059$2.70M0.2%N/A1.791% 8/17/2021PVG Asset Management Corp189,616$375K1.2%+1,241.0%0.249% 8/17/2021Boothbay Fund Management LLC155,069$307K0.0%N/A0.203% 8/16/2021Morgan Stanley91,106$180K0.0%+197,956.5%0.120% 8/16/2021State Street Corp322,716$639K0.0%N/A0.423% 8/16/2021Goldman Sachs Group Inc.68,399$135K0.0%N/A0.090% 8/13/2021Altium Capital Management LP446,000$883K0.2%N/A0.585% 8/13/2021Geode Capital Management LLC651,318$1.29M0.0%+10.6%0.854% 8/11/2021BlackRock Inc.1,649,929$3.27M0.0%-3.9%2.165% 8/6/2021Asset Management Corp IL ADV91,500$181K0.1%N/A0.120% 8/4/2021Envestnet Asset Management Inc.92,919$184K0.0%+256.9%0.122% 8/2/2021Advisor Group Holdings Inc.17,751$35K0.0%+94.9%0.023% 8/2/2021McAdam LLC55,978$86K0.0%+52.8%0.073% 5/19/2021Virtu Financial LLC179,030$329K0.0%N/A0.235% 5/14/2021PVG Asset Management Corp14,140$26K0.1%N/A0.019% 5/13/2021Renaissance Technologies LLC157,500$290K0.0%-52.1%0.207% 5/13/2021Bank of New York Mellon Corp48,602$89K0.0%+18.7%0.064% 5/12/2021Northern Trust Corp145,515$268K0.0%+129.5%0.191% 5/12/2021Geode Capital Management LLC588,718$1.08M0.0%+190.6%0.772% 5/12/2021UBS Group AG68,202$125K0.0%+10,794.9%0.089% 5/11/2021Rockefeller Capital Management L.P.20,000$36K0.0%N/A0.026% 5/10/2021GSA Capital Partners LLP160,775$296K0.0%+80.5%0.211% 5/7/2021BlackRock Inc.1,716,168$3.16M0.0%+43.7%2.251% 5/6/2021Prospera Financial Services Inc31,300$58K0.0%-20.4%0.041% 5/6/2021Meitav Dash Investments Ltd.44,000$81K0.0%N/A0.058% “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late.5/4/2021Envestnet Asset Management Inc.26,037$48K0.0%N/A0.034% 4/28/2021 JGP Wealth Management LLC15,000$28K0.0%N/A0.020% 4/26/2021McAdam LLC36,641$67K0.0%N/A0.048% 2/17/2021Worth Venture Partners LLC233,947$512K0.4%N/A2.592% 2/16/2021Squarepoint Ops LLC111,978$245K0.0%+621.3%1.241% 2/12/2021Prospera Financial Services Inc39,300$86K0.0%N/A0.435% 2/11/2021Northern Trust Corp63,402$139K0.0%N/A0.703% 2/10/2021Renaissance Technologies LLC329,022$721K0.0%N/A3.646% 2/9/2021Perkins Capital Management Inc.150,000$329K0.2%N/A1.662% 2/9/2021Bank of New York Mellon Corp40,945$90K0.0%N/A0.454% 2/5/2021BlackRock Inc.1,194,434$2.62M0.0%+1,867.1%13.235% 2/4/2021GSA Capital Partners LLP89,067$195K0.0%N/A0.987% (Data available from 1/1/2016 forward) HEPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HEPA shares? During the previous two years, the following institutional investors and hedge funds held shares of Hepion Pharmaceuticals shares: Armistice Capital LLC ($526K), and Anson Funds Management LP ($155K), Virtu Financial LLC ($42K).Learn more on HEPA's institutional investors. What percentage of Hepion Pharmaceuticals stock is owned by institutional investors? 17.24% of Hepion Pharmaceuticals stock is owned by institutional investors. Learn more on HEPA's institutional investor holdings. Which institutional investors have been buying Hepion Pharmaceuticals stock? The following institutional investors have purchased Hepion Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($544K), Anson Funds Management LP ($231.85K), and Virtu Financial LLC ($32.34K). How much institutional buying is happening at Hepion Pharmaceuticals? Institutional investors have bought a total of 808,185 shares in the last 24 months. This purchase volume represents approximately $2.84M in transactions. Related Companies FLGC Major Shareholders SNSE Major Shareholders BGXX Major Shareholders AIM Major Shareholders HOTH Major Shareholders CRVO Major Shareholders RLMD Major Shareholders CLDI Major Shareholders TXMD Major Shareholders ACXP Major Shareholders This page (NASDAQ:HEPA) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
